CAS: 69207-52-9 - methyl 2-tetradecyloxirane-2-carboxylate
Formula:C18H34O3
InChI:InChI=1S/C18H34O3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-18(16-21-18)17(19)20-2/h3-16H2,1-2H3
InChI key:InChIKey=RSSDZUNGAWCFPT-UHFFFAOYSA-N
SMILES:O=C(OC)C1(OC1)CCCCCCCCCCCCCC
- Synonyms:
- (±)-2-Tetradecyl-2-oxiranecarboxylic Acid Methyl Ester
- 2-Oxiranecarboxylic Acid, 2-Tetradecyl-, Methyl Ester
- 69207-52-9
- McN 3716
- Methyl 2-tetradecylglycidate
- Methyl palmoxirate
- NSC 359682
- Oxiranecarboxylic acid, 2-tetradecyl-, methyl ester
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
methyl 2-tetradecylglycidate REF: IN-DA00G0U1CAS: 69207-52-9 | 98% | To inquire | Tue 10 Dec 24 | |
Methyl Palmoxirate REF: TR-M325583CAS: 69207-52-9 | - - - | 1,574.00 € | Tue 21 Jan 25 | |
McN3716 REF: TM-T11978CAS: 69207-52-9 | 100% | 327.00 €~4,661.00 € | Mon 27 Jan 25 | |
McN3716 REF: 3D-UCA20752CAS: 69207-52-9 | Min. 95% | - - - | Discontinued product |
Methyl Palmoxirate
Controlled ProductCAS:69207-52-9
Formula:
C18H34O3
Color and Shape:
Neat
Molecular weight:
298.461
Ref: TR-M325583
1g | 1,574.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
McN3716
CAS:69207-52-9
McN3716 is a carnitine palmitoyltransferase I (CPT-1) inhibitor for the study of metabolic diseases.
Formula:
C18H34O3
Purity:
100%
Color and Shape:
Solid
Molecular weight:
298.46
Ref: TM-T11978
1mg | 327.00 € | ||
5mg | 900.00 € | ||
10mg | 1,119.00 € | ||
25mg | 1,486.00 € | ||
50mg | 1,839.00 € | ||
100mg | 2,322.00 € | ||
500mg | 4,661.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
McN3716
CAS:69207-52-9
McN3716 is a reversible inhibitor of the enzyme 3-phosphoinositide-dependent protein kinase 1 (PDK1) that blocks …
Formula:
C18H34O3
Purity:
Min. 95%
Molecular weight:
298.46 g/mol
Ref: 3D-UCA20752
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |